Discontinuation report PMS-RANITIDINE 300 MG
| Report ID | 135504 |
| Drug Identification Number | 02242454 |
| Brand name | PMS-RANITIDINE 300 MG |
| Common or Proper name | RANITIDINE |
| Company Name | PHARMASCIENCE INC |
| Market Status | DORMANT |
| Active Ingredient(s) | RANITIDINE |
| Strength(s) | 300MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 250 |
| ATC code | A02BA |
| ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2021-03-10 |
| Remaining supply date | 2021-03-10 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | Demand transferred to 5760696624 pms-RANITIDINE 300mg TABS 100 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2021-03-11 | French | Compare |
| v1 | 2021-03-11 | English | Compare |
Showing 1 to 2 of 2